Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease
Tatsuki Noguchi(The University of Tokyo), Yu Sato(Toho University), Koji Oba(The University of Tokyo), Koji Okabayashi(Keio University), Tsunekazu Mizushima(The University of Osaka), Hisashi Nagahara(Osaka City University), Fumikazu Koyama(Nara Medical University), Hiroki Ohge(Hiroshima University Hospital), Kazutaka Yamada(Takano Hospital), Kinya Okamoto(Tokyo Yamate Medical Center), Michio Itabashi(Tokyo Women's Medical University), Yusuke Kinugasa(The Japanese Society of Gastroenterological Surgery), Hiroki Ikeuchi(Hyogo Medical University), Hideaki Kimura(Yokohama City University Medical Center), Yoichi Ajioka(Niigata University), Hideki Ueno(National Defense Medical College), Yoshifumi Shimada(Niigata University), Koya Hida(Kyoto University Hospital), Koji Daito(Kindai University), Motoi Uchino(Hyogo Medical University), Yoshiki Okita(Mie University), Takayuki Yamamoto(Yokkaichi Social Insurance Hospital), Yusuke Mizuuchi(Kyushu University), Shinji Tanaka(Onomichi General Hospital), Atsuo Maemoto(Sapporo Higashi Tokushukai Hospital), Kazuhiro Watanabe(Tohoku University), Kenichi Sugihara(Toujinkai Hospital), Kenichi Takahashi(Tohoku Rosai Hospital), Kitaro Futami(Fukuoka University), Junji Okuda(Osaka University of Pharmaceutical Sciences), Soichiro Ishihara(University of Tokyo Hospital), Tsunekazu Hanai(Fujita Health University)
Cited by 38
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600